Issue 3/2021
Content (19 Articles)
US Food and Drug Administration regulatory updates in neuro-oncology
Gautam U. Mehta, Amy K. Barone, Diana Bradford, Erin Larkins, Janice Kim, Lee Pai-Scherf, Adnan Jaigirdar, Mirat Shah, Suparna Wedam, Laleh Amiri-Kordestani, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Harpreet Singh
Genetic manipulation of adhesion GPCR CD97/ADGRE5 modulates invasion in patient-derived glioma stem cells
D. G. Eichberg, T. I. Slepak, A. L. Pascoini, R. J. Komotar, M. E. Ivan
Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit
Michael Castro, Anusha Pampana, Aftab Alam, Rajan Parashar, Swaminathan Rajagopalan, Deepak Anil Lala, Kunal Ghosh Ghosh Roy, Sayani Basu, Annapoorna Prakash, Prashant Nair, Vishwas Joseph, Ashish Agarwal, Poornachandra G, Liptimayee Behura, Shruthi Kulkarni, Nikita Ray Choudhary, Shweta Kapoor
Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated γδ T lymphocytes
David A. Rosso, Micaela Rosato, Juan Iturrizaga, Nazareno González, Carolina M. Shiromizu, Irene A. Keitelman, Juan V. Coronel, Fernando D. Gómez, María M. Amaral, Alejandra T. Rabadan, Gabriela V. Salamone, Carolina C. Jancic
Pattern of technology diffusion in the adoption of stereotactic laser interstitial thermal therapy (LITT) in neuro-oncology
Reid A. Johnson, Truong H. Do, Elise F. Palzer, Samuel W. Cramer, Jacob T. Hanson, Jared D. Huling, Daniel G. Hoody, Abigail L. Rice, Amber N. Piazza, Madeleine A. Howard, Robert A. McGovern, Clark C. Chen
What does a non-response to induction chemotherapy imply in high-risk medulloblastomas?
Jihane Adelon, Christelle Dufour, Stéphanie Foulon, Julien Masliah Planchon, David Meyronnet, Franck Bourdeaut, Gilles Palenzuela, Fanny Fouyssac, Sandra Raimbault, Emilie De Carli, Sébastien Klein, Anne Pagnier, Anne-Isabelle Bertozzi, Angélique Rome, Audrey David, Sylvie Chabaud, Cécile Faure-Conter
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients
Michael J. Lehner, Jinesh S. Gheeya, Bilal A. Siddiqui, Sudhakar Tummala
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma
Nancy Ann Oberheim Bush, Jacob S. Young, Yalan Zhang, Cecilia L. Dalle Ore, Annette M. Molinaro, Jennie Taylor, Jennifer Clarke, Michael Prados, Steve E. Braunstein, David R. Raleigh, Susan M. Chang, Mitchel S. Berger, Nicholas A. Butowski
Peri-radiosurgical administration of bevacizumab improves radiographic response to single and fractionated stereotactic radiosurgery for large brain metastasis
Yi-Lun Chen, Abel Po-Hao Huang, Chia-Chun Wang, Hung-Yi Chen, Ya-Fang Chen, Furen Xiao, Shao-Lun Lu, Jason Chia-Hsien Cheng, Feng-Ming Hsu
Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes
I-Chia Liu, Adam L. Holtzman, Ronny L. Rotondo, Daniel J. Indelicato, Sridharan Gururangan, Robert Cavaliere, Bridgette Carter, Christopher G. Morris, Daryoush Tavanaiepour, Michael S. Rutenberg
Correction to: Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes
I-Chia Liu, Adam L. Holtzman, Ronny L. Rotondo, Daniel J. Indelicato, Sridharan Gururangan, Robert Cavaliere, Bridgette Carter, Christopher G. Morris, Daryoush Tavanaiepour, Michael S. Rutenberg
Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey
Niklas Schäfer, Elisabeth Bumes, Fabian Eberle, Viola Fox, Florian Gessler, Frank A. Giordano, Juergen Konczalla, Julia Onken, Malte Ottenhausen, Moritz Scherer, Matthias Schneider, Hartmut Vatter, Ulrich Herrlinger, Patrick Schuss
A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma
Keren Porper, Yael Shpatz, Luba Plotkin, Ronit Goldman Pechthold, Alisa Talianski, Colin E. Champ, Orit Furman, Ariel Shimoni-Sebag, Zvi Symon, Uri Amit, Rina Hemi, Hannah Kanety, Yael Mardor, Zvi R. Cohen, Elisheva Jan, Hili Genssin, Yair Anikster, Leor Zach, Yaacov R. Lawrence
The clinical relevance of laboratory prognostic scores for patients with radiosurgically treated brain metastases of non-pulmonary primary tumor
Anna Cho, Helena Untersteiner, Fabian Fitschek, Farjad Khalaveh, Philip Pruckner, Noemi Pavo, Karl Rössler, Christian Dorfer, Brigitte Gatterbauer, Christoph Höller, Manuela Schmidinger, Josa M. Frischer
The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes
William C. Newman, Jacob Goldberg, Sergio W. Guadix, Samantha Brown, Anne S. Reiner, Katherine Panageas, Kathryn Beal, Cameron W. Brennan, Viviane Tabar, Robert J. Young, Nelson S. Moss
Implantation of Carmustine wafers after resection of malignant glioma with and without opening of the ventricular system
Christoph Bettag, Abdelhalim Hussein, Alexandra Sachkova, Hans Christoph Bock, Dorothee Mielke, Veit Rohde, Tammam Abboud
Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with gamma knife radiosurgery
Niels J. van Ruitenbeek, Vincent K. Y. Ho, Hans M. Westgeest, Laurens V. Beerepoot, Patrick E. J. Hanssens
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
Müller Mareike, Staub-Bartelt Franziska, Ehrmann Julia, Hänggi Daniel, Sabel Michael, Felsberg Jörg, Rapp Marion
Diffusion tractography for awake craniotomy: accuracy and factors affecting specificity
Natalie L. Voets, Pieter Pretorius, Martin D. Birch, Vasileios Apostolopoulos, Richard Stacey, Puneet Plaha